Pulmonary Large-cell Neuroendocrine Carcinoma
2 clinical trials · Condition
◉ Watch Pulmonary Large-cell Neuroendocrine Carcinoma
| Record | Firm | Date |
|---|---|---|
| Durvalumab With Carboplatin and Etoposide Chemotherapy in Pulmonary Large-cell Neuroendocrine Carcinoma (LCNEC) (NCT06418087) | Gruppo Oncologico Italiano di Ricerca Clinica | 2022-05-27 |
| Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma (NCT02943798) | Shanghai Chest Hospital | 2016-12-01 |
Track Pulmonary Large-cell Neuroendocrine Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.